Financial Architects, Inc Glaukos Corp Transaction History
Financial Architects, Inc
- $657 Million
- Q2 2023
Shares
2 transactions
Others Institutions Holding GKOS
# of Institutions
352Shares Held
46.8MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.24 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$906 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$337 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$302 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$253 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.35B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...